On December 1, 2016, Impel NeuroPharma, Inc. closed the transaction. The company has received $22,297,064 in funding from 10 investors in the first tranche of its series C round. Of the total money received, the company received $21,000,000 from new investors, Vivo Capital, LLC, 5AM Venture Management LLC, and venBio LLC. All the three investors invested $7,000,000 each. These investors will invest additional $5,000,000 each in the company upon accomplishment of certain development and business milestones.